Researchers find promising targets for a tuberculosis vaccine and medication by monitoring T cell activity. The goal of the La Jolla Institute for Immunology (LJI) is to direct the creation of ...

Until recently, the only adjuvants appropriate for use in TB vaccines were either ineffective at stimulating T-cell responses or were too toxic for human use. This situation has rapidly changed in ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

At least a handful of patients have developed active TB after receiving ... target and kill tumor cells. Six months into receiving the experimental treatment, the man developed an odd-looking nodule ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough, ...

As Kansas deals with one of the largest tuberculous outbreaks in the nation since the 1950s, Californians may be wondering ...

It is easier for the immune cells of patients capable of absorbing vitamin D to fight tuberculosis. In the female patient, vitamin D does not do anything; her body simply does not respond to it ...

If not, you can get sick again. If you have TB germs in your body but they haven’t become active, you have what doctors call “latent TB.” You can’t spread the disease to others.

“Tuberculosis cells are clumpy and seem to always stick close to each other, so defining cell boundaries didn’t seem possible ...